Product News |
EMAA Product News Preview Your guide to the european Masters in Anti-Aging Medicine
30 September – 1 october, Paris, france ineX Flexible cannulae diSPodErm
Application Accessory For 10 years INEX, France, has developed and produced a complete range of micro-cannulae for dermal filler and hyaluronic acid micro- injections in delicate areas around the face. The Dispoderm® flexible cannulas are available from 30 to 18 gauge with blunt tip and side exit port. These can be use for the non-traumatic, non-painful injection of fillers in delicate areas. Other unique products include sharp needles as small as 32G for botulinum toxin injections. INEX is the premium manufacturer of aesthetic cannulae and needles.
Contact INEX●
www.aestheticgroup.fr EMAA Stand Number E-20
nesCens, bY Laboratoires GenoLier
Intensive exfoliating preparation—face and neck
KErAtolYtic comPlEX
Application Topical treatment The Keratolytic Complex combines a poly-hydroxy acid with an intensive exfoliating agent. Their synergistic effects encourage surface desquamation of the skin to refine its corneocyte covering. Acting as a high-performance restoration process for the skin covering, the Keratolytic Complex works to: improve the mechanical properties of the tissues; improve the properties of the skin barrier; increase the skin’s resistance to environmental assaults; counteract the effects of photo-ageing. The NESCENS resurfacing technique is recommended to act on the appearance of flaws in the skin’s profile. It leaves skin feeling retexturised and visibly smoothed, as if retautened. Skin roughness appears diminished and pores are tightened. The complexion appears more even. The youthful look of facial features is restored.
Contact NESCENS ●
www.nescens.com EMAA Stand Number D-24
aesthetiC FaCtors, LLC Dermatological and aesthetic treatments SElPhYl®
Application Preparation of autologous platelet-rich plasma Aesthetic Factors, LLC, is focused on autologous therapies to enhance rejuvenation in dermatology and plastic surgery. It’s lead product, SELPHYL® Brand Autologous System is a platelet-rich fibrin matrix produced from a patient’s own blood and injected into the skin to address a variety of unmet needs aesthetic medicine. Unlike hyaluronic acid based dermal fillers that are synthetic or produced from animal or bacterial sources, SELPHYL uses the patient’s own blood to naturally produce and release a host of biologic growth factors that promote tissue regeneration.
Contact Aesthetic Factors, LLC●
www.Selphyl.com EMAA Stand Number B-19
72 ❚ September 2011 |
prime-journal.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76